DS-8201a
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colorectal Neoplasm
Conditions
Colorectal Neoplasm
Trial Timeline
Feb 23, 2018 → Nov 10, 2020
NCT ID
NCT03384940About DS-8201a
DS-8201a is a phase 2 stage product being developed by Daiichi Sankyo for Colorectal Neoplasm. The current trial status is completed. This product is registered under clinical trial identifier NCT03384940. Target conditions include Colorectal Neoplasm.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04132960 | Phase 2 | Completed |
| NCT03368196 | Phase 1 | Completed |
| NCT03384940 | Phase 2 | Completed |
| NCT03366428 | Phase 1 | Completed |
| NCT03248492 | Phase 2 | Terminated |
Competing Products
20 competing products in Colorectal Neoplasm